{"id":955,"date":"2006-03-01T12:02:00","date_gmt":"2006-03-01T11:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2006\/leserbrief-neue-proteaseinhibitoren"},"modified":"2006-03-01T12:02:00","modified_gmt":"2006-03-01T11:02:00","slug":"leserbrief-neue-proteaseinhibitoren","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2006\/leserbrief-neue-proteaseinhibitoren","title":{"rendered":"Leserbrief: Neue Proteaseinhibitoren"},"content":{"rendered":"<p>Dr. H.F. aus Berlin schreibt: >> In der Tabelle Ihrer Kleinen Mitteilung (AMB 2006, 40, 4) sind einige Fehler bei der Dosierung der neuen Proteaseinhibitoren zu bemerken \u2026<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. H.F. aus Berlin schreibt: >> In der Tabelle Ihrer Kleinen Mitteilung (AMB 2006, 40, 4) sind einige Fehler bei der Dosierung der neuen Proteaseinhibitoren zu bemerken \u2026<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[122,1401,123,1023,1363,125,1051,1402,1405,1403,1404,120,1400,1399],"class_list":["post-955","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-aids","tag-amprenavir-ritonavir","tag-antiretrovirale-therapie","tag-atazanavir","tag-fosamprenavir","tag-hiv-infektion","tag-hiv-protease-hemmer","tag-indinavir-ritonavir","tag-lopinavir-ritonavir","tag-nelfinavir","tag-proteaseinhibitoren","tag-ritonavir","tag-saquinavir-ritonavir","tag-tipranavir"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=955"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/955\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}